Build Your Comparison

Side-by-side financial analysis
TOI logo
TOI
AIOT logo
AIOT
TRAK logo
TRAK
GEOS logo
GEOS
VEEV logo
VEEV
JPM logo
JPM
KO logo
KO
Try popular comparisons:

Stock Comparison

TOI vs AIOT vs TRAK vs GEOS vs VEEV vs JPM vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TOI
The Oncology Institute, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$5.41B
5Y Perf.+1054.3%
AIOT
PowerFleet, Inc.

Communication Equipment

TechnologyNASDAQ • US
Market Cap$574M
5Y Perf.-7.7%
TRAK
ReposiTrak, Inc.

Software - Application

TechnologyNYSE • US
Market Cap$171M
5Y Perf.-38.5%
GEOS
Geospace Technologies Corporation

Oil & Gas Equipment & Services

EnergyNASDAQ • US
Market Cap$94M
5Y Perf.-19.2%
VEEV
Veeva Systems Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$25.92B
5Y Perf.-12.8%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+58.6%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.61B
5Y Perf.+29.8%

TOI vs AIOT vs TRAK vs GEOS vs VEEV vs JPM vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TOI logoTOI
AIOT logoAIOT
TRAK logoTRAK
GEOS logoGEOS
VEEV logoVEEV
JPM logoJPM
KO logoKO
IndustryMedical - Care FacilitiesCommunication EquipmentSoftware - ApplicationOil & Gas Equipment & ServicesMedical - Healthcare Information ServicesBanks - DiversifiedBeverages - Non-Alcoholic
Market Cap$5.41B$574M$171M$94M$25.92B$896.00B$355.61B
Revenue (TTM)$546M$436M$23M$101M$3.32B$280.33B$49.28B
Net Income (TTM)$-44M$-32M$7M$-29M$942M$57.05B$13.70B
Gross Margin14.8%55.2%85.0%14.3%75.0%60.0%61.7%
Operating Margin-6.0%1.7%32.2%-30.3%28.8%25.9%29.3%
Forward P/E25.4x17.6x14.4x25.3x
Total Debt$104M$287M$510K$974K$96M$942.38B$45.49B
Cash & Equiv.$34M$49M$29M$26M$1.42B$343.34B$10.27B

TOI vs AIOT vs TRAK vs GEOS vs VEEV vs JPM vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TOI
AIOT
TRAK
GEOS
VEEV
JPM
KO
StockJun 24Jun 26Return
The Oncology Instit… (TOI)1001154.3+1054.3%
PowerFleet, Inc. (AIOT)10092.3-7.7%
ReposiTrak, Inc. (TRAK)10061.5-38.5%
Geospace Technologi… (GEOS)10080.8-19.2%
Veeva Systems Inc. (VEEV)10087.2-12.8%
JPMorgan Chase & Co. (JPM)100158.6+58.6%
The Coca-Cola Compa… (KO)100129.8+29.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: TOI vs AIOT vs TRAK vs GEOS vs VEEV vs JPM vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AIOT leads in 2 of 7 categories (7-stock set), making it the strongest pick for growth and revenue expansion and dividend income and shareholder returns. The Oncology Institute, Inc. is the stronger pick specifically for recent price momentum and sentiment. TRAK, VEEV, JPM, and KO also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇AIOT emerged as the overall leader. Track its performance:
TOI
The Oncology Institute, Inc.
The Momentum Pick

TOI is the #2 pick in this set and the best alternative if momentum is your priority.

  • +100.4% vs TRAK's -54.5%
Best for: momentum
AIOT
PowerFleet, Inc.
The Growth Play

AIOT has the current edge in this matchup, primarily because of its strength in growth exposure.

  • Rev growth 66.3%, EPS growth 60.6%, 3Y rev CAGR 42.2%
  • 66.3% revenue growth vs GEOS's -18.3%
  • 17.8% yield, 1-year raise streak, vs KO's 2.5%, (3 stocks pay no dividend)
Best for: growth exposure
TRAK
ReposiTrak, Inc.
The Value Pick

TRAK ranks third and is worth considering specifically for valuation efficiency.

  • PEG 0.74 vs KO's 2.26
  • 31.0% margin vs GEOS's -28.9%
Best for: valuation efficiency
GEOS
Geospace Technologies Corporation
The Energy Pick

In this particular matchup, GEOS is outpaced on most metrics by others in the set.

Best for: energy exposure
VEEV
Veeva Systems Inc.
The Defensive Pick

VEEV is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 0.69, Low D/E 1.3%, current ratio 4.89x
  • Beta 0.69, current ratio 4.89x
  • Beta 0.69 vs AIOT's 2.71, lower leverage
Best for: sleep-well-at-night and defensive
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • 465.8% 10Y total return vs KO's 121.1%
  • Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Best for: income & stability and long-term compounding
KO
The Coca-Cola Company
The Niche Pick

KO is the clearest fit if your priority is efficiency.

  • 13.1% ROA vs TOI's -26.5%, ROIC 15.8% vs -41.2%
Best for: efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthAIOT logoAIOT66.3% revenue growth vs GEOS's -18.3%
ValueJPM logoJPMLower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
Quality / MarginsTRAK logoTRAK31.0% margin vs GEOS's -28.9%
Stability / SafetyVEEV logoVEEVBeta 0.69 vs AIOT's 2.71, lower leverage
DividendsAIOT logoAIOT17.8% yield, 1-year raise streak, vs KO's 2.5%, (3 stocks pay no dividend)
Momentum (1Y)TOI logoTOI+100.4% vs TRAK's -54.5%
Efficiency (ROA)KO logoKO13.1% ROA vs TOI's -26.5%, ROIC 15.8% vs -41.2%

TOI vs AIOT vs TRAK vs GEOS vs VEEV vs JPM vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Biotech & Healthcare Stocks Theme

These companies are key players in the Biotech & Healthcare Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
TOIThe Oncology Institute, Inc.
FY 2025
Health Care, Patient Service
49.5%$229M
Fee For Service
32.1%$149M
Capitated Revenue
17.4%$80M
Clinical Research Trials And Other Revenue
1.0%$5M
AIOTPowerFleet, Inc.
FY 2024
Service
62.8%$84M
Product
37.2%$50M
TRAKReposiTrak, Inc.
FY 2025
Subscription and Support
98.6%$22M
Professional Services
1.4%$305,226
GEOSGeospace Technologies Corporation
FY 2025
Product
91.4%$104M
Rental
8.6%$10M
VEEVVeeva Systems Inc.
FY 2026
Subscription Services Veeva Commercial Cloud
86.9%$1.3B
Professional Services Veeva Commercial Cloud
13.1%$189M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

TOI vs AIOT vs TRAK vs GEOS vs VEEV vs JPM vs KO — Financial Metrics

Side-by-side numbers across 7 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTOILAGGINGVEEV

Who Leads Where

TRAK leads in 1 of 6 categories

JPM leads 1 • TOI leads 1 • KO leads 1 • AIOT leads 0 • GEOS leads 0 • VEEV leads 0 • 2 tied

Explore the data ↓
VEEVVeeva Systems Inc.
0leads
GEOSGeospace Technologies…
0leads
AIOTPowerFleet, Inc.
0leads
KOThe Coca-Cola Company
1leads
JPMJPMorgan Chase & Co.
1leads
TRAKReposiTrak, Inc.
1leads
TOIThe Oncology Institut…
1leads
6 Total Categories

Income & Cash Flow (Last 12 Months)

TRAK leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 11943.4x TRAK's $23M. TRAK is the more profitable business, keeping 31.0% of every revenue dollar as net income compared to GEOS's -28.9%. On growth, AIOT holds the edge at +47.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTOI logoTOIThe Oncology Inst…AIOT logoAIOTPowerFleet, Inc.TRAK logoTRAKReposiTrak, Inc.GEOS logoGEOSGeospace Technolo…VEEV logoVEEVVeeva Systems Inc.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$546M$436M$23M$101M$3.3B$280.3B$49.3B
EBITDAEarnings before interest/tax-$26M$69M$8M-$20M$1.1B$81.4B$15.5B
Net IncomeAfter-tax profit-$44M-$32M$7M-$29M$942M$57.0B$13.7B
Free Cash FlowCash after capex-$26M$3M$7M-$32M$518M$100.9B$12.6B
Gross MarginGross profit ÷ Revenue+14.8%+55.2%+85.0%+14.3%+75.0%+60.0%+61.7%
Operating MarginEBIT ÷ Revenue-6.0%+1.7%+32.2%-30.3%+28.8%+25.9%+29.3%
Net MarginNet income ÷ Revenue-8.0%-7.4%+31.0%-28.9%+28.4%+20.4%+27.8%
FCF MarginFCF ÷ Revenue-4.7%+0.6%+31.9%-31.3%+15.6%+36.0%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year+41.2%+47.4%-0.5%+9.5%+16.3%+12.1%
EPS Growth (YoY)Latest quarter vs prior year+90.5%-25.5%+1.8%-11.7%+14.6%+16.0%+18.2%
TRAK leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

JPM leads this category, winning 3 of 7 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 45% valuation discount to VEEV's 29.3x P/E. Adjusting for growth (PEG ratio), TRAK offers better value at 0.78x vs KO's 2.43x — a lower PEG means you pay less per unit of expected earnings growth.

MetricTOI logoTOIThe Oncology Inst…AIOT logoAIOTPowerFleet, Inc.TRAK logoTRAKReposiTrak, Inc.GEOS logoGEOSGeospace Technolo…VEEV logoVEEVVeeva Systems Inc.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
Market CapShares × price$5.4B$574M$171M$94M$25.9B$896.0B$355.6B
Enterprise ValueMkt cap + debt − cash$5.5B$813M$143M$69M$24.6B$1.50T$390.8B
Trailing P/EPrice ÷ TTM EPS-9.83x-9.81x26.89x-9.55x29.33x16.00x27.18x
Forward P/EPrice ÷ next-FY EPS est.25.43x17.61x14.40x25.27x
PEG RatioP/E ÷ EPS growth rate0.78x1.61x0.90x2.43x
EV / EBITDAEnterprise value multiple51.19x19.11x20.59x18.36x26.39x
Price / SalesMarket cap ÷ Revenue10.75x1.58x7.56x0.85x8.11x3.20x7.42x
Price / BookPrice ÷ Book value/share1.13x3.64x0.74x3.69x2.47x10.40x
Price / FCFMarket cap ÷ FCF20.35x18.70x8.88x67.15x
JPM leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — TRAK and KO each lead in 4 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-24 for GEOS. GEOS carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), TRAK scores 7/9 vs GEOS's 1/9, reflecting strong financial health.

MetricTOI logoTOIThe Oncology Inst…AIOT logoAIOTPowerFleet, Inc.TRAK logoTRAKReposiTrak, Inc.GEOS logoGEOSGeospace Technolo…VEEV logoVEEVVeeva Systems Inc.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity-6.6%+0.1%-24.2%+13.4%+15.9%+41.1%
ROA (TTM)Return on assets-26.5%-3.4%+0.1%-19.9%+11.0%+1.3%+13.1%
ROICReturn on invested capital-41.2%-4.3%+21.4%-7.4%+12.9%+4.5%+15.8%
ROCEReturn on capital employed-33.7%-5.1%+12.9%-8.6%+13.8%+8.9%+17.3%
Piotroski ScoreFundamental quality 0–94371657
Debt / EquityFinancial leverage0.64x0.01x0.01x0.01x2.60x1.33x
Net DebtTotal debt minus cash$70M$238M-$28M-$25M-$1.3B$599.0B$35.2B
Cash & Equiv.Liquid assets$34M$49M$29M$26M$1.4B$343.3B$10.3B
Total DebtShort + long-term debt$104M$287M$509,973$974,000$96M$942.4B$45.5B
Interest CoverageEBIT ÷ Interest expense-4.96x0.47x182.09x-187.88x0.74x10.70x
Evenly matched — TRAK and KO each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TOI leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $5,250 for VEEV. Over the past 12 months, TOI leads with a +100.4% total return vs TRAK's -54.5%. The 3-year compound annual growth rate (CAGR) favors TOI at 111.1% vs VEEV's -5.7% — a key indicator of consistent wealth creation.

MetricTOI logoTOIThe Oncology Inst…AIOT logoAIOTPowerFleet, Inc.TRAK logoTRAKReposiTrak, Inc.GEOS logoGEOSGeospace Technolo…VEEV logoVEEVVeeva Systems Inc.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date+44.7%-19.6%-20.4%-59.0%-27.3%-0.5%+20.3%
1-Year ReturnPast 12 months+100.4%-11.0%-54.5%+9.5%-43.5%+21.8%+17.2%
3-Year ReturnCumulative with dividends+841.3%-11.5%+10.7%-11.0%-16.2%+138.2%+47.0%
5-Year ReturnCumulative with dividends-47.4%-11.5%+63.0%-17.2%-47.5%+118.2%+65.6%
10-Year ReturnCumulative with dividends-45.3%-11.5%+4.7%-60.7%+367.2%+465.8%+121.1%
CAGR (3Y)Annualised 3-year return+111.1%-4.0%+3.4%-3.8%-5.7%+33.6%+13.7%
TOI leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than AIOT's 2.71 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs GEOS's 24.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTOI logoTOIThe Oncology Inst…AIOT logoAIOTPowerFleet, Inc.TRAK logoTRAKReposiTrak, Inc.GEOS logoGEOSGeospace Technolo…VEEV logoVEEVVeeva Systems Inc.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5001.95x2.71x0.97x2.09x0.69x0.94x-0.20x
52-Week HighHighest price in past year$5.58$5.88$21.03$29.89$310.50$337.25$84.04
52-Week LowLowest price in past year$2.02$2.77$6.94$6.52$148.05$262.71$65.35
% of 52W HighCurrent price vs 52-week peak+95.2%+71.8%+44.7%+24.3%+51.4%+95.1%+98.3%
RSI (14)Momentum oscillator 0–10065.365.947.836.243.859.160.6
Avg Volume (50D)Average daily shares traded1.6M1.5M126K213K2.3M7.0M12.7M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — AIOT and KO each lead in 1 of 2 comparable metrics.

Analyst consensus: TOI as "Buy", AIOT as "Buy", TRAK as "Buy", GEOS as "Hold", VEEV as "Buy", JPM as "Buy", KO as "Buy". Consensus price targets imply 155.0% upside for TRAK (target: $24) vs 4.2% for KO (target: $86). For income investors, AIOT offers the higher dividend yield at 17.85% vs TRAK's 0.92%.

MetricTOI logoTOIThe Oncology Inst…AIOT logoAIOTPowerFleet, Inc.TRAK logoTRAKReposiTrak, Inc.GEOS logoGEOSGeospace Technolo…VEEV logoVEEVVeeva Systems Inc.JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHoldBuyBuyBuy
Price TargetConsensus 12-month target$8.00$8.00$24.00$235.38$339.75$86.13
# AnalystsCovering analysts5518436148
Dividend YieldAnnual dividend ÷ price+17.8%+0.9%+1.9%+2.5%
Dividend StreakConsecutive years of raises1401556
Dividend / ShareAnnual DPS$0.75$0.09$5.95$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.5%+1.9%+0.7%+0.7%+3.9%+0.2%
Evenly matched — AIOT and KO each lead in 1 of 2 comparable metrics.
Key Takeaway

TRAK leads in 1 of 6 categories (Income & Cash Flow). JPM leads in 1 (Valuation Metrics). 2 tied.

Best OverallThe Oncology Institute, Inc. (TOI)Leads 1 of 6 categories
Loading custom metrics...

TOI vs AIOT vs TRAK vs GEOS vs VEEV vs JPM vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO a better buy right now?

For growth investors, The Oncology Institute, Inc.

(TOI) is the stronger pick with 27. 8% revenue growth year-over-year, versus -18. 3% for Geospace Technologies Corporation (GEOS). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate The Oncology Institute, Inc. (TOI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus Veeva Systems Inc. at 29. 3x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ReposiTrak, Inc. wins at 0. 74x versus The Coca-Cola Company's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -47. 5% for Veeva Systems Inc. (VEEV). Over 10 years, the gap is even starker: JPM returned +465. 8% versus GEOS's -60. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus PowerFleet, Inc. 's 2. 71β — meaning AIOT is approximately -1451% more volatile than KO relative to the S&P 500. On balance sheet safety, Geospace Technologies Corporation (GEOS) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO?

By revenue growth (latest reported year), The Oncology Institute, Inc.

(TOI) is pulling ahead at 27. 8% versus -18. 3% for Geospace Technologies Corporation (GEOS). On earnings-per-share growth, the picture is similar: PowerFleet, Inc. grew EPS 60. 6% year-over-year, compared to -52. 0% for Geospace Technologies Corporation. Over a 3-year CAGR, AIOT leads at 42. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO?

ReposiTrak, Inc.

(TRAK) is the more profitable company, earning 30. 9% net margin versus -14. 1% for PowerFleet, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -10. 2% for GEOS. At the gross margin level — before operating expenses — TRAK leads at 83. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, ReposiTrak, Inc. (TRAK) is the more undervalued stock at a PEG of 0. 74x versus The Coca-Cola Company's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 25. 4x for ReposiTrak, Inc. — 11. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRAK: 155. 0% to $24. 00.

08

Which pays a better dividend — TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO?

In this comparison, AIOT (17.

8% yield), KO (2. 5% yield), JPM (1. 9% yield), TRAK (0. 9% yield) pay a dividend. TOI, GEOS, VEEV do not pay a meaningful dividend and should not be held primarily for income.

09

Is TOI or AIOT or TRAK or GEOS or VEEV or JPM or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Geospace Technologies Corporation (GEOS) carries a higher beta of 2. 09 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +121. 1%, GEOS: -60. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TOI and AIOT and TRAK and GEOS and VEEV and JPM and KO?

These companies operate in different sectors (TOI (Healthcare) and AIOT (Technology) and TRAK (Technology) and GEOS (Energy) and VEEV (Healthcare) and JPM (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TOI is a small-cap high-growth stock; AIOT is a small-cap income-oriented stock; TRAK is a small-cap quality compounder stock; GEOS is a small-cap quality compounder stock; VEEV is a mid-cap high-growth stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock. AIOT, TRAK, JPM, KO pay a dividend while TOI, GEOS, VEEV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.